NO970682L - Diarylalkanderivater inneholdende en alisyklisk gruppe, deres fremstilling og deres terapeutiske og profylaktiske anvendelse - Google Patents

Diarylalkanderivater inneholdende en alisyklisk gruppe, deres fremstilling og deres terapeutiske og profylaktiske anvendelse

Info

Publication number
NO970682L
NO970682L NO970682A NO970682A NO970682L NO 970682 L NO970682 L NO 970682L NO 970682 A NO970682 A NO 970682A NO 970682 A NO970682 A NO 970682A NO 970682 L NO970682 L NO 970682L
Authority
NO
Norway
Prior art keywords
therapeutic
preparation
alicyclic group
derivatives containing
prophylactic use
Prior art date
Application number
NO970682A
Other languages
English (en)
Other versions
NO970682D0 (no
NO308737B1 (no
Inventor
Koichi Fujimoto
Naoki Tanaka
Fumitoshi Asai
Taketoshi Ogawa
Teiichiro Koga
Tatsuo Tanimoto
Yoshio Tsujita
Hiroyuki Koike
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO970682D0 publication Critical patent/NO970682D0/no
Publication of NO970682L publication Critical patent/NO970682L/no
Publication of NO308737B1 publication Critical patent/NO308737B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
NO970682A 1996-02-15 1997-02-14 Diarylalkanderivater inneholdende en alisyklisk gruppe, deres anvendelse ved fremstilling av et legemiddel, og farmasøytiske preparater inneholdende disse NO308737B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2804196 1996-02-15

Publications (3)

Publication Number Publication Date
NO970682D0 NO970682D0 (no) 1997-02-14
NO970682L true NO970682L (no) 1997-08-18
NO308737B1 NO308737B1 (no) 2000-10-23

Family

ID=12237667

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970682A NO308737B1 (no) 1996-02-15 1997-02-14 Diarylalkanderivater inneholdende en alisyklisk gruppe, deres anvendelse ved fremstilling av et legemiddel, og farmasøytiske preparater inneholdende disse

Country Status (16)

Country Link
US (1) US5843983A (no)
EP (1) EP0790235A1 (no)
KR (1) KR970061864A (no)
CN (1) CN1174190A (no)
AU (1) AU713236B2 (no)
CA (1) CA2197599A1 (no)
CZ (1) CZ43597A3 (no)
HU (1) HUP9700444A3 (no)
ID (1) ID15946A (no)
IL (1) IL120199A (no)
MX (1) MX9701252A (no)
NO (1) NO308737B1 (no)
NZ (1) NZ314227A (no)
RU (1) RU2139277C1 (no)
TW (1) TW393452B (no)
ZA (1) ZA971130B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP2001002252A0 (en) 1999-02-23 2001-09-30 Pfizer Prod Inc Monoamine reuptake inhibitors for treatment of CNS disorders.
BRPI0507670A (pt) 2004-02-13 2007-07-17 Warner Lambert Co moduladores do receptor de androgênio
EP1737813A1 (en) 2004-04-13 2007-01-03 Warner-Lambert Company LLC Androgen modulators
BRPI0509980A (pt) 2004-04-22 2007-10-16 Warner Lambert Co moduladores de androgênio
TW200724139A (en) 2005-05-05 2007-07-01 Warner Lambert Co Androgen modulators

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3381013A (en) * 1964-01-15 1968-04-30 Bristol Myers Co Heterocyclicamino ethers of benzylphenols
US4220603A (en) * 1977-10-07 1980-09-02 Mitsubishi Chemical Industries, Limited Pharmaceutically active (omega-aminoalkoxy)bibenzyls
US4871721A (en) 1988-01-11 1989-10-03 E. R. Squibb & Sons, Inc. Phosphorus-containing squalene synthetase inhibitors
JPH02304022A (ja) * 1989-05-18 1990-12-17 Mitsubishi Kasei Corp セロトニン拮抗剤
MX9100517A (es) * 1990-08-06 1992-04-01 Smith Kline French Lab Compuestos
IE912759A1 (en) * 1990-08-06 1992-02-12 Smith Kline French Lab Compounds
US5102907A (en) 1990-09-13 1992-04-07 Merck & Co., Inc. Novel squalene synthetase inhibitors
US5252586A (en) * 1990-09-28 1993-10-12 The Du Pont Merck Pharmaceutical Company Ether derivatives of alkyl piperidines and pyrrolidines as antipsychotic agents
GB9113031D0 (en) * 1991-06-17 1991-08-07 Smithkline Beecham Plc Compounds
EP0629190A1 (en) * 1992-01-28 1994-12-21 Smithkline Beecham Plc Compounds as calcium channel antagonists
CA2110251A1 (en) * 1992-11-30 1994-05-31 Koichi Fujimoto Alpha, omega-diarylalkane derivatives, their preparation and their use in the treatment and prevention of circulatory diseases and psychosis
GB9226111D0 (en) * 1992-12-15 1993-02-10 Smithkline Beecham Plc Madicaments
GB9411045D0 (en) * 1994-06-02 1994-07-20 Smithkline Beecham Plc Compounds and use
GB9417532D0 (en) * 1994-08-31 1994-10-19 Zeneca Ltd Aromatic compounds
GB9420557D0 (en) * 1994-10-12 1994-11-30 Zeneca Ltd Aromatic compounds

Also Published As

Publication number Publication date
EP0790235A1 (en) 1997-08-20
IL120199A0 (en) 1997-06-10
RU2139277C1 (ru) 1999-10-10
US5843983A (en) 1998-12-01
HUP9700444A2 (hu) 1998-05-28
KR970061864A (ko) 1997-09-12
TW393452B (en) 2000-06-11
CZ43597A3 (en) 1997-12-17
AU713236B2 (en) 1999-11-25
HU9700444D0 (en) 1997-04-28
IL120199A (en) 2000-11-21
CN1174190A (zh) 1998-02-25
MX9701252A (es) 1998-04-30
ID15946A (id) 1997-08-21
NO970682D0 (no) 1997-02-14
CA2197599A1 (en) 1997-08-16
HUP9700444A3 (en) 1998-07-28
AU1259797A (en) 1997-08-21
ZA971130B (en) 1997-09-09
NO308737B1 (no) 2000-10-23
NZ314227A (en) 1998-01-26

Similar Documents

Publication Publication Date Title
NO991815D0 (no) Oksadiazoler, fremgangsmÕter for deres fremstilling og deres anvendelse som medikamenter
NO961160D0 (no) Cykliske forbindelser, deres fremstilling og anvendelse
DK0869126T3 (da) Dithiolanderivater, deres fremstilling og deres terapeutiske virkning
DK0740668T3 (da) Tetracykliske derivater, fremgangsmåde til deres fremstilling og deres anvendelse
DK0966454T3 (da) Disubstituerede bicykliske heterocykler, deres fremstilling og deres anvendelse som lægemidler
NO944187L (no) Isokinoliner, fremgangsmåte for deres fremstilling og anvendelse
NO943682D0 (no) Imidazol-4-yl-piperidin-derivater, deres fremstilling og terapeutiske anvendelse
IS5353A (is) Asýl-píperasínil-pýrimídínafleiður, framleiðsla og notkun þeirra sem lyfja
DK1161434T3 (da) Pyridopyranoazepinderivater, deres fremstilling og terapeutiske anvendelse
NO955326D0 (no) Isokinolinderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse
NO20001934D0 (no) 3-Substituerte tetrahydropyridopyrimidinon-derivater, deres fremstilling og anvendelse
NO992676D0 (no) 1,4-diazabicyklo[2,2,2]okt-2-ylmetylderivater, deres fremstilling og terapeutiske anvendelse
DK0835254T3 (da) Oxazolidinonderivater, deres fremstilling og deres terapeutiske anvendelse
NO962477D0 (no) Benzamidderivater, deres fremstilling og deres terapautiske anvendelse
NO940130D0 (no) Benzimidazolderivater, fremgangsmaate for deres fremstilling og te rapeutisk anvendelse derav
NO984624L (no) Nye furan-diarylmetyliden-derivater, fremgangsmÕte for deres fremstilling og terapeutiske anvendelser derav
NO970682L (no) Diarylalkanderivater inneholdende en alisyklisk gruppe, deres fremstilling og deres terapeutiske og profylaktiske anvendelse
NO955242D0 (no) Piperidinderivater, fremgangsmåte for fremstilling derav og deres terapeutiske anvendelse
NO973230D0 (no) Nye peptider, deres fremstilling og anvendelse
DK0763535T3 (da) Piperidinylmethyloxazolidin-2-on-derivater, deres fremstilling og deres anvendelse som centralnervesystem-aktive forbindelser
NO20000066D0 (no) 6-pyrrolidin-2-ylpyrindin-derivater, deres fremstilling og deres farmasoeytiske anvendelse
HUP0203468A3 (en) Betha-d-5-thioxylose derivatives, preparation method and therapeutic use thereof
NO981002D0 (no) Karboksylsyrederivater, deres fremstilling og anvendelse
NO982549D0 (no) 5-naftalen-1-yl-1,3-dioksan-derivater, fremstilling og terapeutisk anvendelse derav
NO992436D0 (no) N(imidazolylbutyl)benzensulfonamidderivater, deres fremstilling og terapeutiske anvendelse

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN AUGUST 2002